Health Technology · Pharmaceuticals: Major · NSE: DRREDDY · data 2026-10-09

Dr. Reddy's Laboratories Ltd.

Health check: Average (5.7/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹1,197

Market cap

₹98,444 cr

P/E

30.2

P/B

2.6

ROE

12.1%

ROCE

12.1%

Debt / equity

0.21

Dividend yield

0.68%

1-year return

-3.9%

52-week high

₹1,414.9

52-week low

₹1,101

Operating margin

9.9%

Growth

Revenue (last 12 months)	₹33,119 cr
Net profit (last 12 months)	₹3,311 cr
Sales growth, 3 years (yearly)	11.0%
Profit growth, 3 years (yearly)	-1.7%

Similar companies

Zydus Lifesciences Limited (ZYDUSLIFE) · Laurus Labs Ltd. (LAURUSLABS) · Mankind Pharma Ltd. (MANKIND) · Alkem Laboratories Ltd. (ALKEM) · Glenmark Pharmaceuticals Limited (GLENMARK)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open DRREDDY in NSE Scanner →